Skip to main content
Top
Published in: Virology Journal 1/2012

Open Access 01-12-2012 | Research

Human Papillomavirus (HPV) genotype 18 variants in patients with clinical manifestations of HPV related infections in Bilbao, Spain

Authors: Sara L Arroyo, Miren Basaras, Elixabete Arrese, Silvia Hernáez, Daniel Andía, Valentín Esteban, Koldo Garcia-Etxebarria, Begoña M Jugo, Ramón Cisterna

Published in: Virology Journal | Issue 1/2012

Login to get access

Abstract

Background

Human papillomavirus (HPV) variants differ in their biological and chemical properties, and therefore, may present differences in pathogenicity. Most authors classified variants based on the phylogenetic analysis of L1 region. Nevertheless, recombination in HPV samples is becoming a usual finding and thus, characterizing genetic variability in other regions should be essential.

Objectives

We aimed to characterize the genetic variability of HPV 18 in 5 genomic regions: E6, E7, E4, L1 and the Upstream Regulatory Region (URR), working with both single infection and multiple HPV infection samples. Furthermore, we aimed to assess the prevalence of HPV 18 variants in our region and look for possible existence of recombination as well as analyze the relationship between these variants and the type of lesion.

Methods

From 2007 to 2010, Clinical Microbiology and Infection Control Department analyzed 44 samples which were positive for HPV 18. Genetic variability was determined in PCR products and variants were assigned to European, Asian-amerindian or African lineage. Recombination and association of variants with different types of lesion was studied.

Results

Genetic analysis of the regions revealed a total of 56 nucleotide variations. European, African and Asian-amerindian variants were found in 25/44 (56.8%), 10/44 (22.7%) and 5/44 (11.4%) samples, respectively. We detected the presence of recombinant variants in 2/44 (4.5%) cases. Samples taken from high-grade squamous intraepithelial lesions (H-SIL) only presented variants with specific-african substitutions.

Conclusions

Multiple HPV infection, non-european HPV variants prevalence and existence of recombination are considered risk factors for HPV persistence and progression of intraepithelial abnormalities, and therefore, should be taken into consideration in order to help to design and optimize diagnostics protocols as well as improve epidemiologic studies.
Our study is one of the few studies in Spain which analyses the genetic variability of HPV18 and we showed the importance of characterizing more than one genomic region in order to detect recombination and classify HPV variants properly.
Appendix
Available only for authorised users
Literature
1.
go back to reference Muñoz N, Castellsague X, de Gonzalez AB, Gissmann L: HPV in the etiology of human cancer. Vaccine. 2006, 24: 1-10. 10.1016/j.vaccine.2005.07.047.CrossRef Muñoz N, Castellsague X, de Gonzalez AB, Gissmann L: HPV in the etiology of human cancer. Vaccine. 2006, 24: 1-10. 10.1016/j.vaccine.2005.07.047.CrossRef
2.
go back to reference Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, et al: Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer. 2007, 121: 621-632. 10.1002/ijc.22527.PubMedCrossRef Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, et al: Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer. 2007, 121: 621-632. 10.1002/ijc.22527.PubMedCrossRef
3.
go back to reference Muñoz N, Bosch FX, Castellsagué X, Díaz M, de Sanjose S, Hammouda D, et al: Against which human papillomavirus types shall we vaccinate and screen? the international perspective. Int J Cancer. 2004, 111: 278-285. 10.1002/ijc.20244.PubMedCrossRef Muñoz N, Bosch FX, Castellsagué X, Díaz M, de Sanjose S, Hammouda D, et al: Against which human papillomavirus types shall we vaccinate and screen? the international perspective. Int J Cancer. 2004, 111: 278-285. 10.1002/ijc.20244.PubMedCrossRef
4.
go back to reference Yamada T, Manos MM, Peto J, Greer CE, Munoz N, Bosch FX, et al: Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J Virol. 1997, 71: 2463-2472.PubMedPubMedCentral Yamada T, Manos MM, Peto J, Greer CE, Munoz N, Bosch FX, et al: Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J Virol. 1997, 71: 2463-2472.PubMedPubMedCentral
5.
go back to reference Ong CK, Chan SY, Campo MS, Campo MS, Fujinaga K, Mavromara-Nazos P, et al: Evolution of human papillomavirus type 18: an ancient phylogenetic root in Africa and intratype diversity reflect coevolution with human ethnic groups. J Virol. 1993, 67: 6424-6431.PubMedPubMedCentral Ong CK, Chan SY, Campo MS, Campo MS, Fujinaga K, Mavromara-Nazos P, et al: Evolution of human papillomavirus type 18: an ancient phylogenetic root in Africa and intratype diversity reflect coevolution with human ethnic groups. J Virol. 1993, 67: 6424-6431.PubMedPubMedCentral
6.
go back to reference de Araujo Souza PS, Sichero L, Macia PC: HPV variants and HLA polymorphisms: the role of variability on the risk of cervical cancer. Future Oncol. 2009, 5: 359-370. 10.2217/fon.09.8.PubMedCrossRef de Araujo Souza PS, Sichero L, Macia PC: HPV variants and HLA polymorphisms: the role of variability on the risk of cervical cancer. Future Oncol. 2009, 5: 359-370. 10.2217/fon.09.8.PubMedCrossRef
7.
go back to reference Sichero L, Ferreira S, Trottier H, Duarte-Franco E, Ferenczy A, Franco EL, et al: High grade cervical lesions are caused preferentially by non-european variants of HPVs 16 and 18. Int J Cancer. 2007, 120: 1763-1768. 10.1002/ijc.22481.PubMedCrossRef Sichero L, Ferreira S, Trottier H, Duarte-Franco E, Ferenczy A, Franco EL, et al: High grade cervical lesions are caused preferentially by non-european variants of HPVs 16 and 18. Int J Cancer. 2007, 120: 1763-1768. 10.1002/ijc.22481.PubMedCrossRef
8.
go back to reference López-Savedra A, González-Maya L, de Ponce León S, García-Carranca A, Mohar A, Lizano M: Functional implication of sequence variation in the long control region and E2 gene among human papillomavirus type 18 variants. Arch Virol. 2009, 154: 747-754. 10.1007/s00705-009-0362-4.CrossRef López-Savedra A, González-Maya L, de Ponce León S, García-Carranca A, Mohar A, Lizano M: Functional implication of sequence variation in the long control region and E2 gene among human papillomavirus type 18 variants. Arch Virol. 2009, 154: 747-754. 10.1007/s00705-009-0362-4.CrossRef
9.
go back to reference de Villiers EM, Fauquet C, Broker TR, Bernard HU, Zur HH: Classification of papillomaviruses. Virology. 2004, 324: 17-27. 10.1016/j.virol.2004.03.033.PubMedCrossRef de Villiers EM, Fauquet C, Broker TR, Bernard HU, Zur HH: Classification of papillomaviruses. Virology. 2004, 324: 17-27. 10.1016/j.virol.2004.03.033.PubMedCrossRef
11.
go back to reference Jiang M, Xi LF, Edelstein ZR, Galloway DA, Olsem GJ, Lin WC, et al: Identification of recombinant human papillomavirus type 16 variants. Virology. 2009, 394: 8-11. 10.1016/j.virol.2009.08.040.PubMedPubMedCentralCrossRef Jiang M, Xi LF, Edelstein ZR, Galloway DA, Olsem GJ, Lin WC, et al: Identification of recombinant human papillomavirus type 16 variants. Virology. 2009, 394: 8-11. 10.1016/j.virol.2009.08.040.PubMedPubMedCentralCrossRef
12.
go back to reference Méndez F, Muñoz N, Posso H, Molano M, Moreno V, van den Brule AJ, et al: Cervical coinfection with human papillomavirus (HPV) types and possible implications for the prevention of cervical cancer by HPV vaccines. J Infect Dis. 2005, 192: 1158-1165. 10.1086/444391.PubMedCrossRef Méndez F, Muñoz N, Posso H, Molano M, Moreno V, van den Brule AJ, et al: Cervical coinfection with human papillomavirus (HPV) types and possible implications for the prevention of cervical cancer by HPV vaccines. J Infect Dis. 2005, 192: 1158-1165. 10.1086/444391.PubMedCrossRef
13.
go back to reference Tinelli A, Leo G, Dell’Edera D, Storelli F, Galante MM, Guido M, et al: Molecular methods for a correct diagnosis of multiple HPV infections and clinical implications for vaccine. Int J Gynecol Cancer. 2011, 21: 545-550. 10.1097/IGC.0b013e31820f5eed.PubMedCrossRef Tinelli A, Leo G, Dell’Edera D, Storelli F, Galante MM, Guido M, et al: Molecular methods for a correct diagnosis of multiple HPV infections and clinical implications for vaccine. Int J Gynecol Cancer. 2011, 21: 545-550. 10.1097/IGC.0b013e31820f5eed.PubMedCrossRef
14.
go back to reference Nielson CM, Harris RB, Flores R, Abrahamsen M, Papenfuss MR, Dunne EF, et al: Multiple-type human papillomavirus infection in male anogenital sites: prevalence and associated factors. Cancer Epidemiol Biomarkers Prev. 2009, 18: 1077-1083. 10.1158/1055-9965.EPI-08-0447.PubMedCrossRef Nielson CM, Harris RB, Flores R, Abrahamsen M, Papenfuss MR, Dunne EF, et al: Multiple-type human papillomavirus infection in male anogenital sites: prevalence and associated factors. Cancer Epidemiol Biomarkers Prev. 2009, 18: 1077-1083. 10.1158/1055-9965.EPI-08-0447.PubMedCrossRef
15.
go back to reference Martin DP, Lemey P, Lott M, Moulton V, Posada D, Lefeuvre P: RDP3: a flexible and fast computer program for analyzing recombination. Bioinformatics. 2010, 26: 2462-2463. 10.1093/bioinformatics/btq467.PubMedPubMedCentralCrossRef Martin DP, Lemey P, Lott M, Moulton V, Posada D, Lefeuvre P: RDP3: a flexible and fast computer program for analyzing recombination. Bioinformatics. 2010, 26: 2462-2463. 10.1093/bioinformatics/btq467.PubMedPubMedCentralCrossRef
16.
go back to reference Smith J: Analyzing the mosaic structure of genes. J Mol Evol. 1992, 34: 126-129.PubMed Smith J: Analyzing the mosaic structure of genes. J Mol Evol. 1992, 34: 126-129.PubMed
17.
go back to reference Xi LF, Kiviat NB, Hildesheim A, Galloway DA, Wheeler CM, Ho J, et al: Human papillomavirus type 16 and 18 variants: race-related distribution and persistence. J Natl Cancer Inst. 2006, 98: 1045-1052. 10.1093/jnci/djj297.PubMedCrossRef Xi LF, Kiviat NB, Hildesheim A, Galloway DA, Wheeler CM, Ho J, et al: Human papillomavirus type 16 and 18 variants: race-related distribution and persistence. J Natl Cancer Inst. 2006, 98: 1045-1052. 10.1093/jnci/djj297.PubMedCrossRef
18.
go back to reference Im SS, Wilczynski SP, Burge RA, Monk BJ: Early stage cervical cancers containing human papillomavirus type 18 DNA have more nodal metastasis and deeper stromal invasion. Clin Cancer Res. 2003, 9: 4145-4150.PubMed Im SS, Wilczynski SP, Burge RA, Monk BJ: Early stage cervical cancers containing human papillomavirus type 18 DNA have more nodal metastasis and deeper stromal invasion. Clin Cancer Res. 2003, 9: 4145-4150.PubMed
19.
go back to reference Burger R, Monk BJ, Kurosaki T, Anton-Culver H, Vasiley SA, Berman ML, et al: Human papillomavirus type 18: association with poor prognosis in early stage cancer. J Natl Cancer Inst. 1996, 88: 1361-1368. 10.1093/jnci/88.19.1361.PubMedCrossRef Burger R, Monk BJ, Kurosaki T, Anton-Culver H, Vasiley SA, Berman ML, et al: Human papillomavirus type 18: association with poor prognosis in early stage cancer. J Natl Cancer Inst. 1996, 88: 1361-1368. 10.1093/jnci/88.19.1361.PubMedCrossRef
20.
go back to reference Hecht J, Kadish A, Jiang G, Burk R: Genetic characterization of the human papillomavirus (HPV) 18 E2 gene in clinical specimens suggests the presence of a subtype with decreased oncogenic potential. Int J Cancer. 1995, 60: 369-376. 10.1002/ijc.2910600317.PubMedCrossRef Hecht J, Kadish A, Jiang G, Burk R: Genetic characterization of the human papillomavirus (HPV) 18 E2 gene in clinical specimens suggests the presence of a subtype with decreased oncogenic potential. Int J Cancer. 1995, 60: 369-376. 10.1002/ijc.2910600317.PubMedCrossRef
21.
go back to reference Villa LL, Sichero L, Rahal P, Caballero O, Ferenczy A, Rohan T, et al: Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasma. J Gen Virol. 2000, 81: 2959-2968.PubMedCrossRef Villa LL, Sichero L, Rahal P, Caballero O, Ferenczy A, Rohan T, et al: Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasma. J Gen Virol. 2000, 81: 2959-2968.PubMedCrossRef
22.
go back to reference Rose B, Steger G, Dong XP, Thompson C, Cossart Y, Tattersall M, et al: Point mutations in SP1 motifs in the upstream regulatory region of human papillomavirus type 18 isolates from cervical cancers increase promoter activity. J Gen Virol. 1998, 79: 1659-1663.PubMedCrossRef Rose B, Steger G, Dong XP, Thompson C, Cossart Y, Tattersall M, et al: Point mutations in SP1 motifs in the upstream regulatory region of human papillomavirus type 18 isolates from cervical cancers increase promoter activity. J Gen Virol. 1998, 79: 1659-1663.PubMedCrossRef
23.
go back to reference Rose B, Thompson CH, Zhang J, Stoeter M, Stephen A, Pfister H, et al: Sequence variation in the upstream regulatory region of HPV 18 isolates from cervical cancers. Gynecol Oncol. 1997, 66: 282-289. 10.1006/gyno.1997.4740.PubMedCrossRef Rose B, Thompson CH, Zhang J, Stoeter M, Stephen A, Pfister H, et al: Sequence variation in the upstream regulatory region of HPV 18 isolates from cervical cancers. Gynecol Oncol. 1997, 66: 282-289. 10.1006/gyno.1997.4740.PubMedCrossRef
24.
go back to reference Meissner J, et al: Sequencing errors in reference HPV clones. Human papillomaviruses. A compilation and analysis of nucleic acid and amino acid sequences. Edited by: Myers G, Baker C, Munger K. 1997, Los Alamos (NM): Theoretical Biology and Biophysics, Los Alamos National Laboratory, 110-123. 3 Meissner J, et al: Sequencing errors in reference HPV clones. Human papillomaviruses. A compilation and analysis of nucleic acid and amino acid sequences. Edited by: Myers G, Baker C, Munger K. 1997, Los Alamos (NM): Theoretical Biology and Biophysics, Los Alamos National Laboratory, 110-123. 3
25.
go back to reference Arias-Pulido H, Peyton CL, Torrez-Martinez N, Anderson DN, Wheeler CM: Human papillomavirus type 18 variant lineages in United States populations characterized by sequence analysis of LCR-E6, E2, and L1 regions. Virology. 2005, 338: 22-34. 10.1016/j.virol.2005.04.022.PubMedCrossRef Arias-Pulido H, Peyton CL, Torrez-Martinez N, Anderson DN, Wheeler CM: Human papillomavirus type 18 variant lineages in United States populations characterized by sequence analysis of LCR-E6, E2, and L1 regions. Virology. 2005, 338: 22-34. 10.1016/j.virol.2005.04.022.PubMedCrossRef
26.
go back to reference Chen Z, DeSalle R, Schiffmn M, Herrero R, Burk RD: Evolutionary dynamics of variant genomes of human papillomavirus types 18, 45 and 97. J Virol. 2009, 83: 1443-1455. 10.1128/JVI.02068-08.PubMedPubMedCentralCrossRef Chen Z, DeSalle R, Schiffmn M, Herrero R, Burk RD: Evolutionary dynamics of variant genomes of human papillomavirus types 18, 45 and 97. J Virol. 2009, 83: 1443-1455. 10.1128/JVI.02068-08.PubMedPubMedCentralCrossRef
27.
go back to reference Ronquist F, Huelsenbeck JP: MrBayes 3: Bayesian phylogenetic inference under mixed models. Bioinformatics. 2003, 19: 1572-1574. 10.1093/bioinformatics/btg180.PubMedCrossRef Ronquist F, Huelsenbeck JP: MrBayes 3: Bayesian phylogenetic inference under mixed models. Bioinformatics. 2003, 19: 1572-1574. 10.1093/bioinformatics/btg180.PubMedCrossRef
Metadata
Title
Human Papillomavirus (HPV) genotype 18 variants in patients with clinical manifestations of HPV related infections in Bilbao, Spain
Authors
Sara L Arroyo
Miren Basaras
Elixabete Arrese
Silvia Hernáez
Daniel Andía
Valentín Esteban
Koldo Garcia-Etxebarria
Begoña M Jugo
Ramón Cisterna
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2012
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-9-258

Other articles of this Issue 1/2012

Virology Journal 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.